US Food and Drug Administration. AvKARE, LLC. issues voluntary nationwide recall of Atovaquone Oral Suspension, USP 750 mg/5 mL due to potential Bacillus cereus contamination. April 1, 2024.

AvKARE, LLC. is voluntarily recalling lot # AW0221A of Atovaquone Oral Suspension, USP 750mg/5mL to the Consumer/User level, due to the potential Bacillus cereus contamination in the product found ...

U.S. annual sales for Baclofen Oral Suspension total approximately $39 million, according to IQVIA data. About ANI Pharmaceuticals, Inc. ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified ...

In a sea of early aughts movies about plucky, 20-something journalists, it was Jenna Rink, “big time magazine editor” who had the life we all craved. With a flashy (and ginormous) New York ...

Former Bartholomew County Prosecutor Bill Nash’s law license will be suspended for 30 days, the Indiana Supreme Court has ruled in resolving his attorney discipline case. Nash’s suspension ...

What is amlodipine used for? Amlodipine is commonly used for the following conditions. High blood pressure (hypertension) Coronary artery disease, which is a type of heart disease Angina, which is ...

Atorvastatin oral suspension should be stored at room temperature between 68 F to 77 F (20 C to 25 C). It can be exposed to temperatures between 59 F to 86 F (15 C to 30 C), for shorter periods of ...

Sea Eagles skipper Daly Cherry-Evans will head to the NRL Judiciary on Tuesday night to contest the grading of the Dangerous Throw offence he was charged for in Round 8. Alongside teammate Haumole ...

The recall involves Lot #AW0221A with an expiration date of August 2025. AvKARE, LLC is recalling 1 lot of Atovaquone Oral Suspension, USP 750 mg/5 mL due to the potential for microbial contamination ...

BAUDETTE, Minn., April 09, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Baclofen Oral Suspension, a generic version of the ...

According to GlobalData’s company profile on Zydus Lifesciences, NSAID cancer drugs was a key innovation area identified from patents. Zydus Lifesciences's grant share as of February 2024 was 71%.